Skip to main content
Signal8

Bodenstedt Matthias

SEC insider (Form 3/4/5 filer). CIK 0001920545. Chief Financial Officer at MoonLake Immunotherapeutics (MLTX). 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in ZUG.

Companies Bodenstedt Matthias has filed insider reports for

  • MoonLake Immunotherapeutics (MLTX): Officer, Chief Financial Officer
Bodenstedt Matthias profile photo

Bodenstedt Matthias

CIK: 0001920545

Transaction Breakdown

Open Market Buys (P)1 (8.3%)

High conviction signal

Open Market Sales (S)7 (58.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MoonLake Immunotherapeutics logo
MLTX

MoonLake Immunotherapeutics

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 22, 2026
    Sale
    Direct
    39.1K shares at avg. $22.04$862K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 18, 2026
    Sale
    Direct
    2.8K shares at avg. $19.60$55K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 17, 2026
    Sale
    Direct
    15.1K shares at avg. $19.68$297K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    May 11, 2026
    Sale
    Direct
    13.7K shares at avg. $20.02$273K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Apr 14, 2026
    Sale
    Direct
    2.4K shares at avg. $19.56$47K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Apr 10, 2026
    Sale
    Direct
    1.9K shares at avg. $19.51$38K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Apr 9, 2026
    Sale
    Direct
    85.9K shares at avg. $18.94$1.6M
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jan 7, 2026
    Award
    Direct
    354.3K shares-
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Dec 19, 2025
    Conversion
    Direct
    294.5K shares-
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Dec 19, 2025
    Disposition
    Direct
    294.5K shares-

1-10 of 12